327 related articles for article (PubMed ID: 19117954)
21. Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray.
Lomri A; Lemonnier J; Delannoy P; Marie PJ
J Bone Miner Res; 2001 Apr; 16(4):705-12. PubMed ID: 11315998
[TBL] [Abstract][Full Text] [Related]
22. Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ).
Zhang W; Yang N; Shi XM
J Biol Chem; 2008 Feb; 283(8):4723-9. PubMed ID: 18084007
[TBL] [Abstract][Full Text] [Related]
23. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
24. Excessive osteoclast activation by osteoblast paracrine factor RANKL is a major cause of the abnormal long bone phenotype in Apert syndrome model mice.
Shin HR; Kim BS; Kim HJ; Yoon H; Kim WJ; Choi JY; Ryoo HM
J Cell Physiol; 2022 Apr; 237(4):2155-2168. PubMed ID: 35048384
[TBL] [Abstract][Full Text] [Related]
25. Activation of Sirt1 decreases adipocyte formation during osteoblast differentiation of mesenchymal stem cells.
Bäckesjö CM; Li Y; Lindgren U; Haldosén LA
J Bone Miner Res; 2006 Jul; 21(7):993-1002. PubMed ID: 16813520
[TBL] [Abstract][Full Text] [Related]
26. Chlormadinone acetate promotes osteoblast differentiation of human mesenchymal stem cells through the ERK signaling pathway.
Kim JM; Lee JE; Ryu SH; Suh PG
Eur J Pharmacol; 2014 Mar; 726():1-8. PubMed ID: 24440171
[TBL] [Abstract][Full Text] [Related]
27. Smads, p38 and ERK1/2 are involved in BMP9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells.
Xu DJ; Zhao YZ; Wang J; He JW; Weng YG; Luo JY
BMB Rep; 2012 Apr; 45(4):247-52. PubMed ID: 22531136
[TBL] [Abstract][Full Text] [Related]
28. Role of the N-terminal peptide of amelogenin on osteoblastic differentiation of human mesenchymal stem cells.
Olivares-Navarrete R; Vesper K; Hyzy SL; Almaguer-Flores A; Boyan BD; Schwartz Z
Eur Cell Mater; 2014 Jul; 28():1-10; discussion 10. PubMed ID: 25017640
[TBL] [Abstract][Full Text] [Related]
29. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
Kaabeche K; Lemonnier J; Le Mée S; Caverzasio J; Marie PJ
J Biol Chem; 2004 Aug; 279(35):36259-67. PubMed ID: 15190072
[TBL] [Abstract][Full Text] [Related]
30. P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells.
Zhao Y; Song T; Wang W; Wang J; He J; Wu N; Tang M; He B; Luo J
PLoS One; 2012; 7(8):e43383. PubMed ID: 22912865
[TBL] [Abstract][Full Text] [Related]
31. Extracellular signal-regulated kinase1/2 activated by fluid shear stress promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells through novel signaling pathways.
Liu L; Shao L; Li B; Zong C; Li J; Zheng Q; Tong X; Gao C; Wang J
Int J Biochem Cell Biol; 2011 Nov; 43(11):1591-601. PubMed ID: 21810479
[TBL] [Abstract][Full Text] [Related]
32. Long-term loading inhibits ERK1/2 phosphorylation and increases FGFR3 expression in MC3T3-E1 osteoblast cells.
Jackson RA; Kumarasuriyar A; Nurcombe V; Cool SM
J Cell Physiol; 2006 Dec; 209(3):894-904. PubMed ID: 16972271
[TBL] [Abstract][Full Text] [Related]
33. Exosome-mediated small interfering RNA delivery inhibits aberrant osteoblast differentiation in Apert syndrome model mice.
Myo AC; Kobayashi Y; Niki Y; Kamimoto H; Moriyama K
Arch Oral Biol; 2023 Sep; 153():105753. PubMed ID: 37348363
[TBL] [Abstract][Full Text] [Related]
34. Myocilin stimulates osteogenic differentiation of mesenchymal stem cells through mitogen-activated protein kinase signaling.
Kwon HS; Johnson TV; Tomarev SI
J Biol Chem; 2013 Jun; 288(23):16882-16894. PubMed ID: 23629661
[TBL] [Abstract][Full Text] [Related]
35. Bent bone dysplasia syndrome reveals nucleolar activity for FGFR2 in ribosomal DNA transcription.
Neben CL; Idoni B; Salva JE; Tuzon CT; Rice JC; Krakow D; Merrill AE
Hum Mol Genet; 2014 Nov; 23(21):5659-71. PubMed ID: 24908667
[TBL] [Abstract][Full Text] [Related]
36. A Ser252Trp mutation in fibroblast growth factor receptor 2 (FGFR2) mimicking human Apert syndrome reveals an essential role for FGF signaling in the regulation of endochondral bone formation.
Chen P; Zhang L; Weng T; Zhang S; Sun S; Chang M; Li Y; Zhang B; Zhang L
PLoS One; 2014; 9(1):e87311. PubMed ID: 24489893
[TBL] [Abstract][Full Text] [Related]
37. Secreted Clusterin protein inhibits osteoblast differentiation of bone marrow mesenchymal stem cells by suppressing ERK1/2 signaling pathway.
Abdallah BM; Alzahrani AM; Kassem M
Bone; 2018 May; 110():221-229. PubMed ID: 29476977
[TBL] [Abstract][Full Text] [Related]
38. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
Ratisoontorn C; Fan GF; McEntee K; Nah HD
Connect Tissue Res; 2003; 44 Suppl 1():292-7. PubMed ID: 12952211
[TBL] [Abstract][Full Text] [Related]
39. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
Lemonnier J; Delannoy P; Hott M; Lomri A; Modrowski D; Marie PJ
Exp Cell Res; 2000 Apr; 256(1):158-67. PubMed ID: 10739663
[TBL] [Abstract][Full Text] [Related]
40. A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome.
Guenou H; Kaabeche K; Mée SL; Marie PJ
Hum Mol Genet; 2005 Jun; 14(11):1429-39. PubMed ID: 15829502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
